MedPath
NMPA Approval

Denosumab Injection

国药准字S20240039

September 3, 2024

Drug Information

地舒单抗注射液

恒盖

注射剂

60mg(1.0ml)/支(预充式注射器)

生物制品

September 3, 2024

Company Information

Applicant Company

吉林省长春市九台经济开发区康宁杰瑞路2号(机场路1898号)

Manufacturing Company

长春九台经济开发区康宁杰瑞路1号(机场路1888号)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地舒单抗注射液 - NMPA 批准文号 | MedPath